View in EDS

Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.

Saved in:
Bibliographic Details
Title: Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
Authors: Strohl WR; BiStro Biotech Consulting, LLC, Bridgewater, NJ, 08807, USA. wrstrohl@gmail.com., Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Sciences Center, Houston, TX, USA., Carroll SF; IGM Biosciences, Inc., Mountainview, CA, USA., Keyt BA; IGM Biosciences, Inc., Mountainview, CA, USA., Strohl LM; Biomedscapes, Bridgewater, NJ, 08807, USA.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2022 May; Vol. 36 (3), pp. 231-323. Date of Electronic Publication: 2022 Apr 27.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35476216
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strohl+WR%22">Strohl WR</searchLink>; BiStro Biotech Consulting, LLC, Bridgewater, NJ, 08807, USA. wrstrohl@gmail.com.<br /><searchLink fieldCode="AU" term="%22Ku+Z%22">Ku Z</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Sciences Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22An+Z%22">An Z</searchLink>; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Sciences Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Carroll+SF%22">Carroll SF</searchLink>; IGM Biosciences, Inc., Mountainview, CA, USA.<br /><searchLink fieldCode="AU" term="%22Keyt+BA%22">Keyt BA</searchLink>; IGM Biosciences, Inc., Mountainview, CA, USA.<br /><searchLink fieldCode="AU" term="%22Strohl+LM%22">Strohl LM</searchLink>; Biomedscapes, Bridgewater, NJ, 08807, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229705305%22">BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy</searchLink> [BioDrugs] 2022 May; Vol. 36 (3), pp. 231-323. <i>Date of Electronic Publication: </i>2022 Apr 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9705305 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-190X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211738804%22">11738804 </searchLink><i>NLM ISO Abbreviation: </i>BioDrugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35476216
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40259-022-00529-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 231
    Titles:
      – TitleFull: Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strohl WR
      – PersonEntity:
          Name:
            NameFull: Ku Z
      – PersonEntity:
          Name:
            NameFull: An Z
      – PersonEntity:
          Name:
            NameFull: Carroll SF
      – PersonEntity:
          Name:
            NameFull: Keyt BA
      – PersonEntity:
          Name:
            NameFull: Strohl LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2022 May
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1179-190X
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
              Type: main
ResultId 1